5CJ6
Crystal Structure of a Selective Androgen Receptor Modulator Bound to the Ligand Binding Domain of the Human Androgen Receptor
Summary for 5CJ6
| Entry DOI | 10.2210/pdb5cj6/pdb |
| Descriptor | Androgen receptor, small peptide, 2-chloro-4-{[(1R,2R)-2-hydroxy-2-methylcyclopentyl]amino}-3-methylbenzonitrile, ... (4 entities in total) |
| Functional Keywords | androgen receptor, nuclear hormone receptor, signaling protein |
| Biological source | Homo sapiens (Human) More |
| Cellular location | Nucleus: P10275 |
| Total number of polymer chains | 2 |
| Total formula weight | 34063.79 |
| Authors | |
| Primary citation | Saeed, A.,Vaught, G.M.,Gavardinas, K.,Matthews, D.,Green, J.E.,Losada, P.G.,Bullock, H.A.,Calvert, N.A.,Patel, N.J.,Sweetana, S.A.,Krishnan, V.,Henck, J.W.,Luz, J.G.,Wang, Y.,Jadhav, P. 2-Chloro-4-[[(1R,2R)-2-hydroxy-2-methyl-cyclopentyl]amino]-3-methyl-benzonitrile: A Transdermal Selective Androgen Receptor Modulator (SARM) for Muscle Atrophy. J.Med.Chem., 59:750-755, 2016 Cited by PubMed Abstract: A transdermal SARM has a potential to have therapeutic benefit through anabolic activity in muscle while sparing undesired effects of benign prostate hyperplasia (BPH) and liver-mediated decrease in HDL-C. 2-Chloro-4-[(2-hydroxy-2-methyl-cyclopentyl)amino]-3-methyl-benzonitrile 6 showed the desired muscle and prostate effects in a preclinical ORX rat model. Compound 6 had minimal effect on HDL-C levels in cynomolgus monkeys and showed human cadaver skin permeability, thus making it an effective tool for proof-of-concept studies in a clinical setting. PubMed: 26683992DOI: 10.1021/acs.jmedchem.5b01168 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.07 Å) |
Structure validation
Download full validation report






